1. Home
  2. TBPH vs TTI Comparison

TBPH vs TTI Comparison

Compare TBPH & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • TTI
  • Stock Information
  • Founded
  • TBPH 2013
  • TTI 1981
  • Country
  • TBPH United States
  • TTI United States
  • Employees
  • TBPH N/A
  • TTI N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • TTI Oil & Gas Production
  • Sector
  • TBPH Health Care
  • TTI Energy
  • Exchange
  • TBPH Nasdaq
  • TTI Nasdaq
  • Market Cap
  • TBPH 418.7M
  • TTI 430.1M
  • IPO Year
  • TBPH N/A
  • TTI 1990
  • Fundamental
  • Price
  • TBPH $9.69
  • TTI $4.05
  • Analyst Decision
  • TBPH Buy
  • TTI Strong Buy
  • Analyst Count
  • TBPH 4
  • TTI 4
  • Target Price
  • TBPH $13.75
  • TTI $7.13
  • AVG Volume (30 Days)
  • TBPH 191.3K
  • TTI 1.3M
  • Earning Date
  • TBPH 11-12-2024
  • TTI 10-29-2024
  • Dividend Yield
  • TBPH N/A
  • TTI N/A
  • EPS Growth
  • TBPH N/A
  • TTI N/A
  • EPS
  • TBPH N/A
  • TTI 0.01
  • Revenue
  • TBPH $63,192,000.00
  • TTI $617,733,000.00
  • Revenue This Year
  • TBPH $6.93
  • TTI N/A
  • Revenue Next Year
  • TBPH $45.31
  • TTI $13.74
  • P/E Ratio
  • TBPH N/A
  • TTI $310.86
  • Revenue Growth
  • TBPH 15.93
  • TTI N/A
  • 52 Week Low
  • TBPH $7.44
  • TTI $2.68
  • 52 Week High
  • TBPH $11.71
  • TTI $5.08
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 70.66
  • TTI 64.24
  • Support Level
  • TBPH $9.38
  • TTI $3.72
  • Resistance Level
  • TBPH $10.10
  • TTI $4.02
  • Average True Range (ATR)
  • TBPH 0.32
  • TTI 0.17
  • MACD
  • TBPH 0.11
  • TTI 0.03
  • Stochastic Oscillator
  • TBPH 83.26
  • TTI 96.15

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Division provides onshore oil and gas operators with comprehensive water management services. The company derives maximum revenue from United states.

Share on Social Networks: